Equity Research, Broker Reports, and media content on QIAGEN NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about QIAGEN NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

QIAGEN NV

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on QIAGEN NV. We currently have 41 research reports from 6 professional analysts.

Date Source Announcement
07Jan24 18:03 DGAP-AHD EQS-Adhoc: QIAGEN N.V.: QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück
07Jan24 18:03 DGAP-AHD EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
03Nov22 21:02 DGAP-AHD EQS-DD: Qiagen N.V.: Dr. Metin Colpan, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent ...
03Nov22 21:02 DGAP-AHD EQS-DD: Qiagen N.V.: Elizabeth E. Tallett, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. ...
02Nov22 21:04 DGAP-AHD EQS-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
02Nov22 21:04 DGAP-AHD EQS-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
02Nov22 21:04 DGAP-AHD EQS-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  • Frequency of research reports

     

  • Research reports on

    QIAGEN NV

  • Providers covering

    QIAGEN NV